ARSA and Parkinson disease: Previous studies [5] have shown that the L300S heterozygous mutation of the ARSA gene may be a risk factor for PD; however, the N352S variant does not reduce the activity of the ARSA enzyme and acts as a molecular chaperone of α-syn to inhibit the aggregation and diffusion of α-syn, playing a protective role.